LBA19 Capivasertib (C) + Paclitaxel (P) As First-Line Treatment of Metastatic Triple-Negative Breast Cancer (mtnbc): the CAPItello-290 Phase III Trial
Annals of Oncology(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined